ALXO

Conviction 95HealthcareScan · Mon, Aug 10, 2026

ALXO$2.06-1.90%

ResistanceSupportVol 14Insider sell

Vol MA14 1.27M

May 11May 28Jun 16Jul 6Jul 23Aug 10

ALX ONCOLOGY HOLDINGS INCPHARMACEUTICAL PREPARATIONSwww.alxoncology.com ↗

Price2.06

Change-1.90%

Gap+0.95%

Rel volume2.73×

Avg volume1.1M

Avg $ vol2.25M

SMA 202.01

SMA 501.89

SMA 2001.77

Price vs 50+9.01%

Price vs 200+16.26%

MA stackbullish

50/200 cross—

Supertrendup · 1.83

RSI (14)54

MACD hist0.00

MACD crossbull · 0d

Stoch %K / %D64 / 76

ADX (14)13

+DI / −DI19 / 15

RSI divergence—

MACD divergence—

ATR %+7.26%

ADR %7.00%

52w high2.60

52w low0.6145

From 52w high-20.77%

Above 52w low+235.23%

New 52w highNo

SqueezeOn · 5d

Bollinger width11.98%

%B0.71

Donchian pos63.66%

Donchian high2.18

Donchian low1.85

AVWAP (52w high)1.93

vs AVWAP high+6.77%

AVWAP (52w low)1.72

vs AVWAP low+19.43%

OBV trendDown

Chaikin MF (20)-0.03

Today vs 20d2.73×

Avg vol (14d)1.27M

Avg vol (20d)1.1M

Avg $ vol (20d)2.25M

Market cap284.85M

RS 3m (vs SPY)+6.60%

RS 6m (vs SPY)-12.17%

RS line new highNo

Trend template8/8

Technical rank61.5

1 week+6.74%

1 month-3.06%

3 months-0.96%

6 months+0.49%

1 year+192.28%

YTD+79.13%

P/E-2.80

P/B2.09

P/S—

P/FCF-3.38

EPS-1.90

Div yield—

ROE-74.67%

ROA-63.24%

Debt/Eq0.07

Current9.71

EV/EBITDA-2.63

Gross margin—

Net margin—

Rev growth—

EPS growth24.59%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value271.87M

Revenue527K

Net income-17.97M

Gross profit—

Free cash flow-84.35M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out134.56M

Employees43

ListedFri, Jul 17, 2020

Free float92.52M

Float %68.8%

Short interest7.46M

Days to cover6.6d

Short volume31.9%

Squeeze score56 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction95 / 100

Pattern quality—

Tech rank61.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.33

Support1.61

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ALXO

All disclosures →

No recent disclosed trades by Congress in ALXO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ALXO · 2 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Wong Shelly SVP, FINANCE AND CAO · Common Stock · 2026-07-01	Sell	1.4K	$3K	2026-07-01	2026-07-06
Klencke Barbara Chief Medical Officer · Stock option (right to buy) · 2026-04-16	Grant	100K	$0	2026-04-16	2026-04-17
Knight Jeff E. Chief Dev & Operating Officer · Stock option (right to buy) · 2026-04-16	Grant	800K	$0	2026-04-16	2026-04-17

SEC filings

EDGAR filings in ALXO · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.